Detection Sensitivity:
Specificity Controls:
Localization: Nuclear staining in HeLa cells treated with anisomycin (1 µg/mL) .
Protocols: Fixed cells incubated with primary antibody (1–25 µg/mL) and visualized using fluorescent secondary antibodies .
Transcriptional Activation: Phosphorylation at S63 (and S73) enhances c-Jun’s ability to activate target genes like FASLG and USP28, implicated in apoptosis and colorectal cancer .
Disease Relevance:
Storage: Lyophilized antibodies stable at -20°C to -70°C; reconstituted solutions stored at 2–8°C for short-term use .
Buffer Compatibility: Performance varies by formulation (e.g., PBS/BSA vs. NFDM/TBST) .
Cross-Reactivity: Most antibodies show strong reactivity with human samples; some cross-react with mouse/rat (e.g., CABP1190) .
Cancer Studies:
Neuroscience:
CUSABIO has engineered vector clones for the expression of a recombinant JUN antibody in mammalian cells. These clones were generated by inserting the JUN antibody heavy and light chains into appropriate plasma vectors. The recombinant JUN antibody was subsequently purified from the culture medium using affinity-chromatography. This antibody is designed to detect JUN protein from human samples in various applications such as ELISA, Western Blot, Immunohistochemistry, and Immunofluorescence.
The phospho-JUN (S63) antibody is specifically designed to detect the endogenous levels of JUN phosphorylated at the Ser63 residue. Phosphorylation of Ser63 within the NH2-terminal transactivation domain of JUN is crucial for its transcriptional activity. Notably, phosphorylation of JUN has also been linked to the mediation of apoptosis when survival signals are interrupted. JUN plays a pivotal role in diverse cellular processes, encompassing proliferation, apoptosis, survival, tumorigenesis, and tissue morphogenesis.
Phosphorylation of c-JUN at Ser63 represents a critical post-translational modification that directly regulates its transcriptional activity. This phosphorylation occurs in the NH2-terminal transactivation domain and is essential for c-JUN's function as a major component of the Activator Protein 1 (AP-1) complex. When phosphorylated at Ser63, c-JUN can effectively dimerize and bind to target DNA sequences, thereby influencing gene transcription. This phosphorylation event plays a crucial regulatory role in multiple cellular processes including proliferation, differentiation, malignant transformation, and apoptosis . The phosphorylation state of c-JUN at Ser63 serves as an important biomarker for JNK pathway activation and cellular stress response mechanisms.
c-JUN phosphorylation by JNK exhibits a defined temporal order with distinctive kinetics. Research demonstrates that Ser63 phosphorylation occurs most rapidly, followed by Ser73, with threonine sites (T91 and T93) being phosphorylated significantly slower. In vitro and in vivo studies reveal the following phosphorylation order: S63 > S73 > T91 ≈ T93 . This temporal pattern has been confirmed through time-resolved NMR studies and immunoblotting with phosphorylation-specific antibodies.
Under physiological conditions with anisomycin stimulation, S63 and S73 phosphorylation occurs with half-times of approximately 12 minutes, while T91 and T93 phosphorylation proceeds more slowly with half-times of 15-17 minutes . These distinct kinetics have important implications for the temporal regulation of c-JUN activity and downstream signaling events.
c-JUN (36 kDa, 331 amino acids) belongs to the bZIP family and Jun subfamily of transcription factors. The transactivation domain (TAD) containing the phosphorylation sites is intrinsically disordered, as evidenced by 2D 1H, 15N correlation spectroscopy showing narrow chemical shift dispersion .
The protein contains four major phosphorylation sites (S63, S73, T91, T93) and a MAPK binding motif (D-motif, residues 32-50) that controls phosphorylation of these sites. Upon phosphorylation, particularly at Ser63 and Ser73, c-JUN undergoes conformational changes that facilitate dimerization and DNA binding, activating its transcriptional functions. Secondary chemical shift analyses show no significant populations of secondary structure in the unphosphorylated state, consistent with the protein's intrinsically disordered nature .
Several methodologies can be employed for detecting phosphorylated c-JUN at Ser63, each with distinct advantages:
HTRF (Homogeneous Time-Resolved Fluorescence) Assay:
Western Blot:
Immunohistochemistry (IHC):
Immunofluorescence (IF):
For high-throughput screening applications, the HTRF assay provides significant advantages in terms of sensitivity, throughput, and reduced sample requirements. The choice of method should be determined by the specific research question, required sensitivity, and available instrumentation.
Based on established research protocols, the following methodology is recommended for stimulating c-JUN phosphorylation at Ser63 in cell culture:
Cell Selection and Culture:
Stimulation Protocol:
Cell Lysis and Detection:
This protocol has been validated to produce robust and reproducible c-JUN phosphorylation that can be readily detected using phospho-specific antibodies. The stimulation conditions can be adjusted based on the specific cell type and experimental requirements.
Validation of phospho-JUN (S63) antibody specificity is crucial for ensuring reliable research outcomes. A comprehensive validation approach includes:
Alanine Substitution Mutants:
Peptide Competition Assay:
Phosphatase Treatment Control:
Treat positive samples with lambda phosphatase
Confirm loss of antibody reactivity after phosphate group removal
Stimulation/Inhibition Controls:
Compare samples from unstimulated cells, anisomycin-stimulated cells, and cells pre-treated with JNK inhibitors
A dose-dependent response should be observed with anisomycin stimulation
NIH-3T3 cells stimulated with increasing concentrations of anisomycin show proportional increases in S63 phosphorylation
Antibody Dilution Series:
These validation steps collectively provide strong evidence for antibody specificity and help identify potential cross-reactivity issues or artifacts in your experimental system.
Research using engineered c-JUN TAD constructs has revealed complex relationships between D-motif positioning and phosphorylation kinetics. The D-motif (residues 32-50) serves as the MAPK binding site that controls phosphorylation of S63, S73, T91, and T93 sites.
In wild-type c-JUN, the D-motif is positioned N-terminal to the phosphorylation sites, with S63 and S73 being closer to the D-motif than T91 and T93. Experiments with transposed D-motif variants (mDock and cDock) revealed that:
Moving the D-motif closer to T91/T93 (mDock variant) did not accelerate their phosphorylation rates
Sites positioned N-terminal to the transposed D-motif showed strongly suppressed phosphorylation
The normally fast S63 site exhibited very slow modification in both mDock and cDock variants
These findings indicate that while spatial proximity to the D-motif contributes to phosphorylation efficiency, it is not the sole determinant. The three-dimensional structural interaction between JNK1 and c-JUN, as well as the primary amino acid sequence surrounding the phosphorylation sites, play crucial roles in determining site-specific phosphorylation kinetics.
Beyond its well-established role in transcriptional activation, phosphorylation of c-JUN at Ser63 mediates several additional cellular functions:
Apoptosis Regulation:
Protein Stability and Turnover:
Phosphorylation at Ser63 can affect c-JUN protein stability and half-life
This post-translational modification may protect c-JUN from ubiquitin-mediated degradation
Protein-Protein Interactions:
Phosphorylated c-JUN can recruit specific co-factors that modulate its activity
Phosphorylation may alter interaction patterns with other transcription factors and regulatory proteins
Cellular Stress Response:
Ser63 phosphorylation serves as a marker for cellular stress response
Different stressors (UV radiation, inflammatory cytokines, oxidative stress) can trigger this phosphorylation through JNK activation
Tissue Morphogenesis:
These diverse functions highlight the central role of c-JUN Ser63 phosphorylation as a regulatory node connecting multiple cellular signaling networks, extending well beyond simple transcriptional control.
The kinetics of c-JUN phosphorylation at Ser63 show subtle but important differences between JNK isoforms. Comparative analyses using recombinant active JNK1 and JNK2 with c-JUN TAD have revealed:
These kinetic differences may have significant implications for understanding the specific roles of different JNK isoforms in various physiological and pathological contexts, providing potential targets for isoform-selective therapeutic interventions.
Researchers frequently encounter several technical challenges when working with phospho-JUN (S63) detection. Here are the most common issues and recommended solutions:
Low Signal Intensity:
Cause: Insufficient stimulation, rapid dephosphorylation, or low antibody sensitivity
Solution: Optimize stimulation conditions (500nM anisomycin for 30 minutes works well); include phosphatase inhibitors in lysis buffer; consider using HTRF assay which offers 8-fold higher sensitivity than Western blot
High Background:
Inconsistent Phosphorylation:
Rapid Dephosphorylation:
Cause: Phosphatase activity during sample preparation
Solution: Work quickly on ice; use comprehensive phosphatase inhibitor cocktails; validate inhibitor effectiveness in your system
Cross-Reactivity with Other Phosphorylation Sites:
Antibody Detection Outside Linear Range:
Implementing these solutions can significantly improve the reliability and reproducibility of phospho-JUN (S63) detection across different experimental platforms.
For rigorous quantitative comparison of phospho-JUN (S63) levels across experimental conditions, consider the following methodological approaches:
HTRF Quantitative Assay:
Normalization Strategies:
Total c-JUN Normalization: Express phospho-JUN (S63) signal relative to total c-JUN levels
Housekeeping Protein Normalization: Normalize to stable reference proteins (β-actin, GAPDH)
Loading Control Normalization: Use total protein stains (Ponceau S, REVERT)
Dose-Response Analysis:
Time-Course Analysis:
Measure phosphorylation at multiple time points (0-30 minutes recommended)
Calculate rates and half-times of phosphorylation
Allows comparison of phosphorylation kinetics under different conditions
In vivo studies show half-times of approximately 12 minutes for S63 phosphorylation following anisomycin treatment
Quantitative Image Analysis:
For IHC/IF applications, use software-based quantification
Include internal controls in each experiment
Consider automated high-content imaging for large-scale analysis
Each of these approaches offers distinct advantages depending on your experimental system and research questions. Combining multiple quantitative methods provides the most robust comparative analysis across experimental conditions.
Interpreting phospho-JUN (S63) data requires careful consideration of the broader signaling context. Key factors to consider include:
Temporal Dynamics:
Multiple Phosphorylation Sites:
Pathway Crosstalk:
JNK is not the only kinase that can influence c-JUN activity
Plk3 can phosphorylate c-JUN independently of JNK
UV irradiation-induced phosphorylation of c-JUN and apoptosis were not significantly affected by JNK knockdown in some systems
Consider analyzing multiple pathway components to determine the specific contribution of each
Cell Type-Specific Regulation:
Different cell types may exhibit distinct patterns of c-JUN phosphorylation
Expression levels of JNK isoforms, phosphatases, and regulatory proteins vary across cell types
Validate findings across multiple relevant cell systems
Functional Correlation:
Phosphorylation at S63 is necessary but not always sufficient for transcriptional activation
Consider complementing phosphorylation data with functional readouts (AP-1 reporter assays, target gene expression)
Establish causality through inhibitor studies or mutation of phosphorylation sites
By integrating these considerations into your data analysis, you can develop a more comprehensive understanding of how phospho-JUN (S63) signaling contributes to specific cellular responses within complex regulatory networks.
Comparative analysis between HTRF and Western blot technologies for phospho-JUN (S63) detection reveals significant differences in performance characteristics:
Parameter | HTRF Technology | Western Blot | Practical Implications |
---|---|---|---|
Sensitivity | 8-fold higher sensitivity demonstrated in direct comparison | Lower sensitivity requires more sample | HTRF can detect lower levels of phosphorylation and requires less cellular material |
Throughput | High (500+ assay points per kit) | Low to moderate | HTRF enables screening applications and larger experimental designs |
Protocol Complexity | Simple mix-and-read, no-wash protocol | Complex multi-step protocol with transfers | HTRF reduces technical variability and hands-on time |
Sample Volume | 16 μL | Typically 20-40 μL | HTRF allows for miniaturization and conservation of precious samples |
Quantification | Direct quantitative readout | Semi-quantitative requiring densitometry | HTRF provides more reliable quantitative comparisons |
Molecular Weight Information | No size discrimination | Provides information on protein size | Western blot can detect unexpected bands or degradation products |
Specificity | High (requires two antibodies in proximity) | Variable (dependent on single antibody) | HTRF may reduce false positives from cross-reactive species |
Experimental validation with HEK293 cells stimulated with 500nM anisomycin for 30 min demonstrated that the HTRF assay could detect phospho-JUN (S63) at significantly lower concentrations than Western blot, making it particularly valuable for experiments with limited sample availability or when detecting subtle changes in phosphorylation levels .
Advanced experimental strategies can elucidate the complex relationship between c-JUN phosphorylation kinetics and downstream transcriptional regulation:
Engineered c-JUN Variants:
Create "swap" variants where sequences containing fast phosphorylation sites (S63/S73) are exchanged with sequences containing slower sites (T91/T93)
Generate phosphomimetic mutants (S63D, S73D) to simulate constitutive phosphorylation
Develop phospho-deficient mutants (S63A, S73A) as negative controls
These engineered variants help dissect the specific contribution of each phosphorylation site to transcriptional activity
Time-Resolved Transcriptomics:
Combine time-course phosphorylation analysis with RNA-seq at multiple time points
Identify temporal relationships between specific phosphorylation events and transcriptional changes
Group target genes based on their activation kinetics relative to c-JUN phosphorylation
Chromatin Immunoprecipitation (ChIP) with Phospho-Specific Antibodies:
Use phospho-JUN (S63) antibodies for ChIP experiments
Determine the genomic binding sites of specifically S63-phosphorylated c-JUN
Compare with binding profiles of total c-JUN or other phosphorylated forms
Live-Cell Imaging with Phosphorylation Biosensors:
Develop FRET-based biosensors for real-time visualization of c-JUN phosphorylation
Correlate spatiotemporal patterns of phosphorylation with transcriptional reporter activity
Analyze single-cell dynamics to capture heterogeneity in response
Targeted Inhibition of Specific Kinases:
These advanced approaches collectively provide a comprehensive view of how the temporal dynamics of c-JUN phosphorylation translate into specific patterns of gene expression, offering insights into the encoding of signal specificity in the JNK pathway.
Integration of phospho-JUN (S63) detection into multi-parameter analyses provides a more comprehensive understanding of stress response signaling networks:
Multiplexed Phospho-Protein Profiling:
Single-Cell Multi-Parameter Analysis:
Utilize phospho-flow cytometry to simultaneously detect phospho-JUN (S63) and other pathway components
Combine with cell cycle markers or apoptosis indicators
Reveals cell-to-cell heterogeneity and identifies distinct cellular subpopulations
Pathway Activity Correlation:
Correlate phospho-JUN (S63) levels with functional readouts:
AP-1 transcriptional reporter activity
Expression of c-JUN target genes
Apoptosis markers
Cell proliferation indices
Dynamic Pathway Modeling:
Integration with -Omics Approaches:
Correlate phospho-JUN (S63) levels with:
Transcriptomic profiles (RNA-seq)
Chromatin accessibility changes (ATAC-seq)
Global phosphoproteomic alterations (phospho-MS)
Identify broader network changes associated with specific phosphorylation patterns
This integrated approach provides a systems-level understanding of how phospho-JUN (S63) signaling contributes to complex cellular responses to various stressors, potentially revealing novel therapeutic targets or biomarkers for stress-related pathologies.